Treatment with angiotensin‐converting enzyme inhibitors (ACEIs) and angiotensin‐receptor blockers (ARBs) suppresses ATR and AF in animal models of AF.593, 594, 595. This evidence concerns the gene ATR and atrial fibrillation.